By showing that incorporating therapy-dependent, nonconstant regulation of PD-L1 enabled a biologically grounded mechanism to reproduce experimental observations, we formulated PD-L1 tumor expression as a dynamic variable (ε), thereby providing a mechanistic basis for both therapeutic synergy and treatment failure within the original model. The gene discussed is CD274; the disease is neoplasm.